Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea · Delayed Price · Currency is KRW 6,830.00
-260.00 (-3.67%)
Sep 22, 2026, 3:30 PM KST
Hyundai Bioscience Market Cap
Hyundai Bioscience has a market cap or net worth of 684.21 billion as of September 22, 2026. Its market cap has increased by 28.60% in one year.
Market Cap
684.21B
Enterprise Value
664.43B
Revenue
3.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,830.00
ChartMarket Cap Chart
Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 684.21B, an increase of 1,340.62%. That is a compound annual growth rate of 11.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 684.21B | 43.49% |
| Dec 30, 2025 | 476.83B | -15.13% |
| Dec 30, 2024 | 561.85B | -45.92% |
| Dec 28, 2023 | 1.04T | -4.44% |
| Dec 29, 2022 | 1.09T | 11.39% |
| Dec 30, 2021 | 976.10B | -6.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orum Therapeutics | 812.31B |
| Pharmicell | 751.85B |
| Chabiotech | 740.02B |
| Komipharm International | 711.84B |
| Onconic Therapeutics | 674.76B |
| GI Innovation | 616.77B |
| Medy-Tox | 434.64B |
| GC Corp. | 433.96B |